Black Pearl Equities launches tender offer for all Selectis Health shares
Take-private interest in smaller healthcare names has been building as liquidity in over-the-counter markets thins and private capital searches for entry points at scale. Black Pearl Equities, a New York-based investment group…
Key takeaways
- Black Pearl Equities, a New York-based investment group acting with its affiliates, announced on July 13 that it commenced a tender offer to acquire every outstanding share of Selectis Health, Inc. common stock.
- Selectis Health trades on the OTCQB market, a tier below Nasdaq and NYSE that requires OTC Markets Group reporting but not exchange-level listing size or float thresholds.
- The bid targets the entire public float, signaling a privatization rather than an influence stake.
- A formal tender offer sets a public clock requiring the buyer to disclose terms and giving existing shareholders a defined acceptance window.
- The offer price has not yet been disclosed, leaving the premium to the last traded price as the key unknown for current shareholders.
Take-private interest in smaller healthcare names has been building as liquidity in over-the-counter markets thins and private capital searches for entry points at scale. Black Pearl Equities, a New York-based investment group acting together with its affiliates, announced on July 13 that it has commenced a tender offer to acquire every outstanding share of common stock in Selectis Health, Inc. The company trades on the OTCQB market.
The offer and what it signals
Black Pearl is bidding for the full float, every share currently in public hands. That all-or-nothing approach points to a privatization rather than an influence stake. A formal tender offer sets a public clock: the buyer must disclose terms, and existing shareholders get a defined acceptance window to respond. That is a different mechanism from a negotiated merger agreement signed before announcement, and the distinction shapes how current holders should read the move.
The OTCQB context
The OTCQB tier sits a level below the Nasdaq and NYSE in listing standards. Companies on this market must satisfy reporting requirements set by OTC Markets Group, but exchange-level thresholds for listing size or float are not required. The effect is a shareholder base that skews toward retail and smaller institutions, with limited sell-side coverage and thin volumes. A formal tender offer into that kind of float can reset the quoted price simply by announcing the intent to buy.
For New York-based investment groups, the OTCQB is a place where the gap between quoted price and private-market value can widen, particularly in healthcare, where regulatory complexity and capital intensity already suppress multiples.
What the announcement leaves open
The offer price is the central fact not yet in hand. For current Selectis Health holders, the premium to the last traded price is the only number that determines whether this is a fair exit or an opportunistic bid. That disclosure, when it arrives through the formal tender documents, is where the story resumes.
Source · 來源